Stay updated on Dolutegravir Study in Completing IMPAACT Participants Clinical Trial
Sign up to get notified when there's something new on the Dolutegravir Study in Completing IMPAACT Participants Clinical Trial page.

Latest updates to the Dolutegravir Study in Completing IMPAACT Participants Clinical Trial page
- Check4 days agoChange DetectedThe ClinicalTrials.gov record for the dolutegravir rollover study is now displayed, with study details and results information, participant criteria, locations, and supporting documents.SummaryDifference61%

- Check11 days agoChange DetectedThe footer displays site revision v3.8.0 instead of v3.7.2. The study record page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check25 days agoChange DetectedAn NIH notice about a terminology transition appears above the page, and the site revision advances from v3.7.1 to v3.7.2. The clinical trial content remains unavailable behind a 403 error.SummaryDifference1%

- Check32 days agoChange DetectedThe footer revision number changes from v3.7.0 to v3.7.1 on the error page.SummaryDifference0.2%

- Check53 days agoChange DetectedAccess to the study page now shows a 403 Forbidden error page instead of the study details. This indicates the record is currently unavailable rather than updated content.SummaryDifference18%

- Check60 days agoChange DetectedThe page revision was updated from v3.6.6 to v3.7.0, indicating a new version of the page template or content management.SummaryDifference0.0%

Stay in the know with updates to Dolutegravir Study in Completing IMPAACT Participants Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dolutegravir Study in Completing IMPAACT Participants Clinical Trial page.